No correlation between circulating ACE activity and VO2max or mechanical efficiency in women

European Journal of Applied Physiology

Volumn 99, Issue 1, 2007, Pages 11-18

  Day, Stephen H ^a   Gohlke, Peter ^b   Dhamrait, Sukhbir S ^c   Williams, Alun G ^d  

^a UNIVERSITY OF WOLVERHAMPTON   (United Kingdom)

^b UNIVERSITY OF KIEL   (Germany)

^c UNIVERSITY COLLEGE HOSPITAL   (United Kingdom)

^d MANCHESTER METROPOLITAN UNIVERSITY   (United Kingdom)

Author keywords

Aerobic power; Angiotensin 1 converting enzyme; Endurance; Genetics

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE; HISTIDINE; LEUCINE; OXYGEN;

ADULT; AEROBIC CAPACITY; ARTICLE; BICYCLE ERGOMETRY; BLOOD SAMPLING; CALORIMETRY; CONTROLLED STUDY; CORRELATION ANALYSIS; ENDURANCE; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; FEMALE; GENE INSERTION; GENETIC ANALYSIS; GENETIC VARIABILITY; GENOTYPE; HUMAN; HUMAN EXPERIMENT; IMMOBILIZATION; NORMAL HUMAN; OXYGEN CONSUMPTION; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; TREADMILL ERGOMETRY;

ADULT; COHORT STUDIES; EXERCISE; EXERCISE TEST; FEMALE; GENOTYPE; HUMANS; MUSCLE, SKELETAL; OXYGEN CONSUMPTION; PEPTIDYL-DIPEPTIDASE A; PHENOTYPE; PHYSICAL ENDURANCE; PHYSICAL FITNESS; POLYMORPHISM, GENETIC;

EID: 33751245915     PISSN: 14396319     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00421-006-0309-3     Document Type: Article

References (44)

1. Bahi L, Koulmann N, Sanchez H, Momken I, Veksler V, Bigard AX, Ventura-Clapier R (2004) Does ACE inhibition enhance endurance performance and muscle energy metabolism in rats? J Appl Physiol 96:59-64
2. BASES (1997) The British Association of Sport and Exercise Sciences Physiological Testing Guidelines. BASES, Leeds
3. Brouwer E (1957) On simple formulae for calculating the heat expenditure and the quantities of carbohydrate and fat oxidised in metabolism of men and animals, from gaseous exchange (oxygen intake and carbonic acid output) and urine-N. Acta Physiol Pharmacol Neerlandica 6:795-802
4. Bryner RW, Toffle RC, Ullrich IH, Yeater RA (1996) Effect of low dose oral contraceptives on exercise performance. Br J Sports Med 30:36-40
5. Cox R, Bouzekri N, Martin S, Southam L, Hugill A, Golamaully M, Cooper R, Adeyemo A, Soubrier F, Ward R, Lathrop GM, Matsuda F, Farrall M (2002) Angiotensin-1-converting enzyme (ACE) plasma concentration is influenced by multiple ACE-linked quantitative trait nucleotides. Hum Mol Genet 11:2969-2977
6. Cushman DW, Cheung HS (1971) Concentrations of angiotensin-converting enzyme in tissues of the rat. Biochim Biophys Acta 250:261-265
7. Danser AH, Schalekamp MA, Bax WA, van den Brink AM, Saxena PR, Riegger GA, Schunkert H (1995) Angiotensin-converting enzyme in the human heart. Effect of the deletion/insertion polymorphism. Circulation 92:1387-1388
8. Depierre D, Roth M (1975) Fluorimetric determination of dipeptidyl carboxypeptidase. (angiotensin- I-converting enzyme). Enzyme 19:65-70
9. Dzau VJ (1988) Tissue renin-angiotensin system: Physiologic and pharmacologic implications. Introduction. Circulation 77:I1-I3
10. Dzau VJ, Bernstein K, Celermajer D, Cohen J, Dahlof B, Deanfield J, Diez J, Drexler H, Ferrari R, van Gilst W, Hansson L, Hornig B, Husain A, Johnston C, Lazar H, Lonn E, Luscher T, Mancini J, Mimran A, Pepine C, Rabelink T, Remme W, Ruilope L, Ruzicka M, Schunkert H, Swedberg K, Unger T, Vaughan D, Weber M (2001) The relevance of tissue angiotensin-converting enzyme: Manifestations in mechanistic and endpoint data. Am J Cardiol 88:1L-20L
11. Fagard R, Lijnen P, Vanhees L, Amery A (1982) Hemodynamic response to converting enzyme inhibition at rest and exercise in humans. J Appl Physiol 53:576-581
12. Gaesser GA, Brooks GA (1975) Muscular efficiency during steady-rate exercise: Effects of speed and work rate. J Appl Physiol 38:1132-1139
13. Gayagay G, Yu B, Hambly B, Boston T, Hahn A, Celermajer DS, Trent RJ (1998) Elite endurance athletes and the ACE I allele-the role of genes in athletic performance. Hum Genet 103:48-50
14. Geisterfer AA, Peach MJ, Owens GK (1988) Angiotensin II induces hypertrophy, not hyperplasia, of cultured rat aortic smooth muscle cells. Circ Res 62:749-756
15. Giudicelli JF, Richer C, Richard C, Thuillez C (1991) Angiotensin converting enzyme inhibition. Systemic and regional hemodynamics in rats and humans. Am J Hypertens 4:258S-262S.
16. Gordon SE, Davis BS, Carlson CJ, Booth FW (2001) ANG II is required for optimal overload-induced skeletal muscle hypertrophy. Am J Physiol 280:E150-E159
17. 2 max is associated with ACE genotype in postmenopausal women. J Appl Physiol 85:1842-1846
18. Ishigai Y, Mori T, Ikeda T, Fukuzawa A, Shibano T (1997) Role of bradykinin-NO pathway in prevention of cardiac hypertrophy by ACE inhibitor in rat cardiomyocytes. Am J Physiol 273:H2659-H2663
19. Janse de Jonge XA (2003) Effects of the menstrual cycle on exercise performance. Sports Med 33:833-851
20. Jeunemaitre X, Lifton RP, Hunt SC, Williams RR, Lalouel JM (1992) Absence of linkage between the angiotensin converting enzyme locus and human essential hypertension. Nat Genet 1:72-75
21. Lebrun CM, Petit MA, McKensie DC, Taunton JE, Prior JC (2003) Decreased maximal aerobic capacity with use of a triphasic oral contraceptive in highly active women: A rendomised controlled trial. Br J Sports Med 37:315-320
22. McArdle WD, Katch FI, Katch VL (2001) Exercise physiology: Energy, nutrition and human performance. Lippincott, Williams and Wilkins, Philidelphia
23. Mittleman KD (1996) Influence of angiotensin II blockade during exercise in the heat. Eur J Appl Physiol Occup Physiol 72:542-547
24. Montgomery HE, Clarkson P, Dollery CM, Prasad K, Losi MA, Hemingway H, Statters D, Jubb M, Girvain M, Varnava A, World M, Deanfield J, Talmud P, McEwan JR, McKenna WJ, Humphries S (1997) Association of angiotensin-converting enzyme gene I/D polymorphism with change in left ventricular mass in response to physical training. Circulation 96:741-747
25. Montgomery HE, Marshall R, Hemingway H, Myerson S, Clarkson P, Dollery C, Hayward M, Holliman DE, Jubb M, World M, Thomas EL, Brynes AE, Saeed N, Barnard M, Bell JD, Prasad K, Rayson M, Talmud PJ, Humphries SE (1998) Human gene for physical performance. Nature 393:221-222
26. Montgomery H, Humphries S, Danilov S (2002) Is genotype or phenotype the better tool for investigating the role of ACE in human cardiovascular disease? Eur Heart J 23:1083-1086
27. Murphey LJ, Gainer JV, Vaughan DE, Brown NJ (2000) Angiotensin-converting enzyme insertion/deletion polymorphism modulates the human in vivo metabolism of bradykinin. Circulation 102:829-832
28. Myerson S, Hemingway H, Budget R, Martin J, Humphries S, Montgomery H (1999) Human angiotensin I-converting enzyme gene and endurance performance. J Appl Physiol 87:1313-1316
29. Nevill AM, Atkinson G (1997) Assessing agreement between measurements recorded on a ratio scale in sports medicine and sports science. Br J Sports Med 31:314-318
30. Nevill AM, Ramsbottom R, Williams C (1992) Scaling physiological measurements for individuals of different body size. Eur J Appl Physiol Occup Physiol. 65(2):110-117
31. Rankinen T, Perusse L, Gagnon J, Chagnon YC, Leon AS, Skinner JS, Wilmore JH, Rao DC, Bouchard C (2000a) Angiotensin-converting enzyme ID polymorphism and fitness phenotype in the HERITAGE Family Study. J Appl Physiol 88:1029-1035
32. Rankinen T, Wolfarth B, Simoneau J-A, Maier-Lenz D, Rauramaa R, Rivera MA, Boulay MR, Chagnon YC, Perusse L, Keul J, Bouchard C (2000b) No association between the angiotensin-converting enzyme ID polymorphism and elite endurance athlete status. J Appl Physiol 88:1571-1575
33. Reneland R, Lithell H (1994) Angiotensin-converting enzyme in human skeletal muscle. A simple in vitro assay of activity in needle biopsy specimens. Scand J Clin Lab Invest 54:105-111
34. Rigat B, Hubert C, Alhenc-Gelas F, Cambien F, Corvol P, Soubrier F (1990) An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 86:1343-1346
35. Shen W, Xu X, Ochoa M, Zhao G, Bernstein RD, Forfia P, Hintze TH (2000) Endogenous nitric oxide in the control of skeletal muscle oxygen extraction during exercise. Acta Physiol Scand 168:675-686
36. Silvestre JS, Bergaya S, Tamarat R, Duriez M, Boulanger CM, Levy BI (2001) Proangiogenic effect of angiotensin-converting enzyme inhibition is mediated by the bradykinin B(2) receptor pathway. Circ Res 89:678-683
37. Tiret L, Poirier O, Nicaud V, Barbaux S, Herrmann SM, Perret C, Raoux S, Francomme C, Lebard G, Tregouet D, Cambien F (2002) Heterogeneity of linkage disequilibrium in human genes has implications for association studies of common diseases. Hum Mol Genet 11 419-429
38. Unger T, Schull B, Rascher W, Lang RE, Ganten D (1982) Selective activation of the converting enzyme inhibitor MK 421 and comparison of its active diacid form with captopril in different tissues of the rat. Biochem Pharmacol 31:3063-3070
39. Williams AG, Rayson MP, Jubb M, World M, Woods DR, Hayward M, Martin J, Humphries SE, Montgomery HE (2000) The ACE gene and muscle performance. Nature 403:614
40. Williams AG, Dhamrait SS, Wootton PTE, Day SH, Hawe E, Payne JR, Myerson SG, World M, Budgett R, Humphries SE, Montgomery HE (2004) Bradykinin receptor gene variant and human physical performance. J Appl Physiol 96:938-942
41. Williams AG, Day SH, Folland JP, Gohlke P, Dhamrait S, Montgomery HE (2005) Circulating angiotensin converting enzyme activity is correlated with muscle strength. Med Sci Sports Exerc 37:944-948
42. Woods DR, World M, Rayson MP, Williams AG, Jubb M, Jamshidi Y, Hayward M, Mary DASG, Humphries SE, Montgomery HE (2002) Endurance enhancement related to the human angiotensin I-converting enzyme I-D polymorphism is not due to differences in the cardiorespiratory response to training. Eur J Appl Physiol 86:240-244
43. Zannad F, van den Broek SA, Bory M (1992) Comparison of treatment with lisinopril versus enalapril for congestive heart failure. Am J Cardiol 70:78C-83C
44. Zhang B, Tanaka H, Shono N, Miura S, Kiyonaga A, Shindo M, Saku K (2003) The I allele of the angiotensin-converting enzyme gene is associated with an increased percentage of slow-twitch type I fibers in human skeletal muscle. Clin Genet 63:139-144